Fed. Circ. Rules Use Code Off Limits In Prandin IP Case
A federal appeals court has thrown out an order directing Novo Nordisk A/S to change back its patent use code for the diabetes drug Prandin, saying generic-drug company Caraco Pharmaceutical Laboratories...To view the full article, register now.
Already a subscriber? Click here to view full article